John Richardson has almost 30 years of public and private sector experience producing client-focused health policy analysis and providing strategic advice. His clients have included federal policymakers, C-suite executives, and the healthcare industry. He has deep substantive knowledge of Medicare policy, quality measurement and value-based payment, and federal legislative, regulatory, and budget processes.
Prior to joining HMA, John was a senior advisor at the Centers for Medicare and Medicaid Services (CMS). He first served in the Office of Legislation, where he focused on the Center for Medicare and Medicaid Innovation (CMMI) and nursing home regulatory issues. He then moved to the Center for Medicare, where he advised on quality measurement issues for the Medicare Shared Savings Program (MSSP).
Prior to CMS, John was vice president at Healthsperien, a Washington, DC-based consulting firm, where he served as the chief strategy officer for the National Partnership for Hospice Innovation (NPHI), a collaborative of over 50 not-for-profit, community-integrated hospice and palliative care providers. In this role, he provided coalition leadership on quality measurement issues, including implementation of the Medicare Hospice Quality Reporting Program, as well as policy analysis, regulatory interpretation, and strategic planning. He oversaw the production of a detailed financial analysis of the hospice industry using Medicare claims and cost report data.
Prior to joining NPHI, John was a principal policy analyst at the Medicare Payment Advisory Commission (MedPAC), a nonpartisan Congressional advisory body. John led MedPAC’s work analyzing and making recommendations to improve Medicare’s quality measurement and value-based payment programs across fee-for-service provider types, ACOs, and Medicare Advantage. He prepared detailed research papers, made presentations at public meetings, and drafted chapters on quality measurement and value-based payment in reports to Congress.
Before joining MedPAC, John was vice president at Avalere Health, a Washington, DC-based advisory firm, where he directed the development and production of client-focused policy analyses on the Medicare Part D prescription drug program, healthcare delivery and payment system reforms, and Medicare demonstration programs. He also made multiple presentations on Part D and other Medicare policy issues to a range of policy and business audiences.
Prior to Avalere, John was the director of program development at CalOptima, a public Medicaid managed care organization serving Orange County, California, with an enrollment of approximately 350,000 Medicaid recipients. Among other projects, John developed an actuarial analysis and business plan for CalOptima to enter a Medicare managed care line of business to serve Medicare-Medicaid “dual eligibles,” and directed enterprise-wide projects to renew the organization’s federal Medicaid waivers and obtain a State of California health plan license.
John began his health policy career as a Medicare program examiner at the White House Office of Management and Budget (OMB), where he served as the lead OMB analyst for Medicare Part B, including physician payment and beneficiary cost-sharing policies. He reviewed, drafted comments on, and recommended changes to proposed regulations and legislation. He routinely briefed OMB and senior White House officials on Medicare policy issues.
John has a Master of Public Policy degree from Duke University and a Bachelor of Arts degree from Harvard University.